Furthermore, this drug can block the process of Epithelial to Mesenchymal Transition (EMT) by TGF-β, and EMT plays a vital role in the development of IPF (Huang et al. 2016). This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.